reports
IN8bio Announces Upcoming Presentation at 2024 European Hematology Ass...
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced today a presentation at the European Hematology Association 2024 Congress, to be held June 13-16 in Madrid, Spain. “We’re excited to share the latest updated interim results from our Phase 1 trial evaluating our gamma-delta T cell therapy INB-100 after haploidentical stem cell transplantation for patients with leukemia at the upcoming EHA c...
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy...
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, presented in an oral session details about its robust and reproducible proprietary clinical-scale gamma-delta T cell manufacturing platform across different donor populations, at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting. In an oral presentation titled: “Healthy Donor vs. Patient Manufac...
IN8bio Reports First Quarter 2024 Financial Results and Recent Corpora...
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - Presented new preclinical data demonstrating proof-of-concept for non-signaling Chimeric Antigen Receptor (nsCAR) platform to effectively target cancer cells while preserving healthy tissue - Demonstrated potential of nsCAR platform to treat previously “undruggable” solid and liquid tumor targets - Announced peer-reviewed publication in ‘Frontiers in Immunology’ on IN8bio’s DeltEx Drug Resistant Immunotherapy (DRI) approach to newly diagnosed glioblastoma multiforme (GBM) - Dosed first patient in auto...
Immersion Corporation Reports First Quarter 2024 Results
AVENTURA, Fla.--(BUSINESS WIRE)-- Immersion Corporation (Nasdaq: IMMR), a leading developer and provider of technologies for haptics, today reported financial results for the first quarter ended March 31, 2024. First Quarter Financial Summary1: Total revenues of $43.8 million, compared to $7.1 million in the first quarter of 2023. GAAP net income was $18.7 million, or $0.59 per diluted share, compared to GAAP net income of $8.3 million, or $0.25 per diluted share, in the first quarter of 2023. GAAP operating expenses of $27.2 million in the first quarter of 2024, compared to $3.8 mi...
Potbelly Corporation Reports Strong Results for First Fiscal Quarter 2...
Potbelly Corporation Reports Strong Results for First Fiscal Quarter 2024 First quarter system-wide sales growth of 1.9% and AWS of $24,250 32 additional new franchise shop commitments in the first quarter Announces $20 million share repurchase program CHICAGO, May 08, 2024 (GLOBE NEWSWIRE) -- Potbelly Corporation (NASDAQ: PBPB), (“Potbelly” or the “Company”) the iconic neighborhood sandwich shop concept, today reported financial results for its first fiscal quarter ended March 31, 2024. Key highlights for the quarter ended March 31, 2024, compared to March 26, 2023: Total revenues d...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in New...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase 2 clinical trial evaluating INB-400 in patients with newly diagnosed glioblastoma multiforme (GBM) has been successfully dosed at the Cleveland Clinic in Ohio. INB-400 is the Company’s first autologous gamma-delta T cell therapy product candidate genetically engineered to survive chem...
Freeport-McMoRan Publishes 2023 Annual Report on Sustainability
PHOENIX--(BUSINESS WIRE)-- Freeport-McMoRan Inc. (NYSE: FCX) today announced the publication of its 2023 Annual Report on Sustainability detailing its environmental, social and governance performance during the year. This report marks FCX’s 23rd year of reporting on its sustainability progress. FCX has a long history of responsible production practices and strives to embrace evolving stakeholder expectations. This press release features multimedia. View the full release here: Richard C. Adkerson, Chairman and Chief Executive Officer, said, “Our sustainability programs are at the forefront of...
IN8bio Announces Oral Presentation at the Upcoming American Society of...
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually. Details of the oral presentation are as follows: Title: Healthy Donor vs Patient Manufactured Autologous Deltex DRI Product; Immunophenotyping...
Freeport-McMoRan First-Quarter 2024 Financial and Operating Results Re...
PHOENIX--(BUSINESS WIRE)-- Freeport-McMoRan Inc. (NYSE: FCX) today announced that it has posted its first-quarter 2024 financial and operating results press release on the Investor Relations page of its website at . This press release features multimedia. View the full release here: As previously indicated on its website, FCX will host a conference call today with securities analysts at 10:00 a.m. Eastern Time to discuss quarterly results. The conference call will be webcast on the Internet along with slides. Interested parties may listen to the conference call live and view the slides on th...
Potbelly Corporation Announces Conference Call to Discuss First Quarte...
Potbelly Corporation Announces Conference Call to Discuss First Quarter 2024 Results on May 8, 2024 CHICAGO, April 17, 2024 (GLOBE NEWSWIRE) -- Potbelly Corporation (NASDAQ: (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop concept, today announced the date for the release of its first quarter 2024 financial results. First Quarter 2024 ResultsPotbelly will report its financial results for the fiscal first quarter 2024 on Wednesday, May 8, 2024 after market close. The Company has scheduled a conference call for investors at 5:00 p.m. Eastern Time on the same day to dis...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Hea...
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18th at 12:30pm ET. The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Attendees interested in viewing t...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
The Pullback Finally Begins; Testing 2-Month Supports We have discussed for months that we will need to see the S&P 500 and Nasdaq 100 (QQQ) close below their 20-day MAs/21-day EMAs for more than 2-3 consecutive days in order to get more cautious. While this has not happened yet (only two consecutive days so far, yesterday and Friday), it does appear to be going in that direction as the U.S. dollar (DXY) climbs to test major $106 resistance, and amid 10- and 30-year Treasury yields breaking abo...
WM WASTE MANAGEMENT INC.
SCCO SOUTHERN COPPER CORPORATION
NGD. NEW GOLD INC.
FCX FREEPORT-MCMORAN INC.
AGI. ALAMOS GOLD INC.
TKO. TASEKO MINES LIMITED
EGO ELDORADO GOLD CORP.
K. KINROSS GOLD CORPORATION
IMG. IAMGOLD CORPORATION
JAGGF JAGUAR MINING INC.
SEA SEABRIDGE GOLD
TECK.B TECK RESOURCES LIMITED CLASS B
RSG REPUBLIC SERVICES INC.
BVN... COMPANIA DE MINAS BUENAVENTURA SAA SPONSORED ADR
WCN WASTE CONNECTIONS INC.
MUX MCEWEN MINING INC.
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell The...
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024 - Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue - Gamma-delta nsCAR platform emerging as an advanced technology for targeting hematologic and solid tumor cancers NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced new preclinical data from its non-signaling gamma-delta T cell based ...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
More Long-Term Breakouts; Bullish Outlook Intact We remain bullish on the S&P 500 and Nasdaq 100 (QQQ), as they both refuse to close below their 20-day MAs or 21-day EMAs for more than 2-3 consecutive days. There is nothing that says this can't continue. With that said, once we do get 2-3 closes below the 20-day MAs or 21-day EMAs on the S&P 500 and QQQ, it would mark the beginning of a pullback (a potentially rapid one, at that), with next supports currently at 4983-5050 on the S&P 500 and $42...
VGZ. VISTA GOLD CORP.
NGD. NEW GOLD INC.
GORO GOLD RESOURCE
FCX FREEPORT-MCMORAN INC.
TKO. TASEKO MINES LIMITED
EGO ELDORADO GOLD CORP.
EDR. ENDEAVOUR SILVER CORP.
SEA SEABRIDGE GOLD
SCCO SUPREME CABLE MANUFACTURING & COMMERCE
SMT SIERRA METALS
CENX CENTURY ALUMINUM COMPANY
KALU KAISER ALUMINUM CORPORATION
BVN... COMPANIA DE MINAS BUENAVENTURA SAA SPONSORED ADR
AA ALCOA CORPORATION
AWCMY ALUMINA LTD ADS
CSTM CONSTELLIUM SE CLASS A
MUX MCEWEN MINING INC.
USGO U.S. GOLDMINING INC
- Ben Pirie
Mining Monthly: March Edition
What you need to know: • Following a long period of consolidation, gold broke out in March, hitting record highs, and continuing to push higher as we enter April. • Silver and copper also had strong months up 10% and 4%, respectively. • More notably, we are finally seeing the equities outperform their underlying metal price with the GDX, SIL, and COPX up 22.7%, 21.1% and 19.4%, respectively, significantly outperforming broader markets. • With precious metals taking the limelight, the rest of the...
Freeport-McMoRan Declares Quarterly Cash Dividends on Common Stock
PHOENIX--(BUSINESS WIRE)-- Freeport-McMoRan Inc. (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX’s common stock payable on May 1, 2024, to shareholders of record as of April 15, 2024. The declaration includes a base dividend of $0.075 per share and variable dividend of $0.075 per share in accordance with FCX's performance-based payout framework. The payment of dividends is at the discretion of the Board, which will consider FCX's financial results, cash requirements, global economic conditions and other factors it deems relevant. FREE...
Moody's downgrades Calumet Specialty Products' CFR to Caa1; negative o...
Moody's Ratings ("Moody's") downgraded the ratings of Calumet Specialty Products Partners, L.P.'s (Calumet), including the Corporate Family Rating (CFR) to Caa1 from B3, Probability of Default Rating (PDR) to Caa1-PD from B3-PD and ratings on the senior unsecured notes to Caa2 from Caa1 and changed ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.